Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 30th, there was short interest totaling 2 shares, a decrease of 99.5% from the October 15th total of 423 shares. Based on an average trading volume of 457 shares, the days-to-cover ratio is presently 0.0 days.
Hikma Pharmaceuticals Stock Performance
OTCMKTS HKMPY opened at $47.75 on Wednesday. The company has a fifty day moving average of $43.57 and a 200 day moving average of $40.76. Hikma Pharmaceuticals has a 1 year low of $31.80 and a 1 year high of $47.75.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals plc is a multinational pharmaceutical company that develops, manufactures and markets a broad range of medicines. Its portfolio includes generic, branded and specialty pharmaceutical products, as well as injectable medicines used in hospitals and other healthcare settings. The company serves healthcare providers, pharmacies and patients across the United States, Europe, the Middle East and North Africa, and other international markets. Its products cover a variety of therapeutic areas, with operations spanning prescription medicines, hospital injectables and established branded treatments.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
